Aller au contenu principal

Analyse moléculaire, modélisation et imagerie de la maladie cancéreuse (AMMICA)

The 20 latest publications

Title Authors Publication date Source
Biomarkers of response to immunotherapy in early stage non-small cell lung cancer Matthieu Roulleaux Dugage, N. Chaput 05/01/23 European Journal of Cancer
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma Marie Breckler, Nathalie Droin 04/03/23 Cancer Discovery
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study Cyril Quivoron, Valérie Camara-Clayette, Vincent Ribrag 04/01/23 American Journal of Hematology
High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia Laure Touchard, Yann Lecluse 03/01/23 Leukemia
Intraoperative Autofluorescence Imaging for Parathyroid Gland Identification during Total Laryngectomy with Thyroidectomy † Muriel Abbaci 02/01/23 Cancers
Caspase Inhibition Modulates Monocyte-Derived Macrophage Polarization in Damaged Tissues Corinne Dupuy, Anny Slama Schwok 02/01/23 International Journal of Molecular Sciences
Serum Metabolome Adaptations Following 12 Weeks of High-Intensity Interval Training or Moderate-Intensity Continuous Training in Obese Older Adults Mélanie Bourgin, Sylvère Durand, Fanny Aprahamian, Déborah Lefevre, M. Chiara Maiuri, Guido Kroemer 02/01/23 Metabolites
Dystrophin myonuclear domain restoration governs treatment efficacy in dystrophic muscle Tudor Manoliu, Corinne Laplace-Builhé 01/10/23 Proceedings of the National Academy of Sciences of the United States of America
Postoperative radiotherapy in non-small cell lung cancer stage IIIA – N2: Focus and perspectives Boris Duchemann 01/01/23 Bulletin du Cancer
Molecular analysis for refractory rare cancers: Sequencing battle continues – learnings for the MOSCATO-01 study Jean Yves Scoazec 01/01/23 Critical Reviews in Oncology/Hematology
Axillary reverse mapping using near-infrared fluorescence imaging in invasive breast cancer (ARMONIC study) Muriel Abbaci, Frédéric De Leeuw, Corinne Laplace-Builhé 12/01/22 European Journal of Surgical Oncology
Re: Kara N. Maxwell, Heather H. Cheng, Jacquelyn Powers, et al. Inherited TP53 Variants and Risk of Prostate Cancer. Eur Urol 2022;81:243–50: Off-core Li-Fraumeni Syndrome Spectrum Cancers: Increasing Interest for Prostate Cancer? Etienne Rouleau 12/01/22 European Urology
CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia Yann Lecluse 12/01/22 Nature Communications
Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform Ludovic Lacroix 12/01/22 Scientific Reports
De novo generation of the NPM-ALK fusion recapitulates the pleiotropic phenotypes of ALK+ ALCL pathogenesis and reveals the ROR2 receptor as target for tumor cells Olivia Bawa, Jean Yves Scoazec 12/01/22 Molecular Cancer
Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers Lydie Cassard, Lisa Boselli, Jonathan Grivel, Ludovic Lacroix, N. Chaput 12/01/22 Journal of Experimental and Clinical Cancer Research
Endothelial and hematopoietic hPSCs differentiation via a hematoendothelial progenitor Tudor Manoliu, Valérie Rouffiac, Karine Ser-Le Roux 12/01/22 Stem Cell Research and Therapy
Quality assessment in light microscopy for routine use through simple tools and robust metrics Tudor Manoliu 11/07/22 Journal of Cell Biology
Genomics to select treatment for patients with metastatic breast cancer Alicia Tran-Dien 10/13/22 Nature
Escherichia coli–Specific CXCL13-Producing T<inf>FH</inf> Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle- Invasive Bladder Cancer Virginie Marty, Nicolas Signolle, Jean Yves Scoazec 10/01/22 Cancer Discovery

Number of publications of the laboratory by scientific field (2016-2021)

Every paper can be classified in one or more scientific fields. The figure below shows the lab's number of publications in each scientific field, according to the ASJC classification (Elsevier)